Old Web
English
Sign In
Acemap
>
authorDetail
>
M. Stacey Ricci
M. Stacey Ricci
Center for Drug Evaluation and Research
Immunology
Medicine
Protein kinase B
Cell
Senescence
4
Papers
234
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
FDA's Approach to Regulating Biosimilars
2017
Clinical Cancer Research
Steven J. Lemery
M. Stacey Ricci
Patricia Keegan
Amy E. McKee
Richard Pazdur
Show All
Source
Cite
Save
Citations (18)
11. Path to Market Approval: Regulatory Perspective of ADC Nonclinical Safety Assessments
2016
M. Stacey Ricci
R. Angelo De Claro
Natalie E. Simpson
Show All
Source
Cite
Save
Citations (0)
FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma
2015
Clinical Cancer Research
Hyon-Zu Lee
Virginia E. Kwitkowski
Pedro L. Del Valle
M. Stacey Ricci
Haleh Saber
Bahru A. Habtemariam
Julie Bullock
Erik Bloomquist
Yuan Li Shen
Xiao Hong Chen
Janice Brown
Nitin Mehrotra
Sarah E. Dorff
Rosane Charlab
Robert C. Kane
Edvardas Kaminskas
Robert Justice
Ann T. Farrell
Richard Pazdur
Show All
Source
Cite
Save
Citations (191)
Dysregulated ΔNp63α Inhibits Expression of Ink4a/arf, Blocks Senescence, and Promotes Malignant Conversion of Keratinocytes
2011
PLOS ONE
Linan Ha
Roshini M. Ponnamperuma
Steven Jay
M. Stacey Ricci
Wendy C. Weinberg
Show All
Source
Cite
Save
Citations (25)
1